
BetterHelp is owned by Teladoc Health, Inc. (NYSE: TDOC), the publicly traded telehealth company headquartered in Purchase, New York. Alon Matas and Danny Bragonier founded BetterHelp in 2013, and Teladoc acquired it in January 2015 for $3.5 million in cash plus a promissory note. The BetterHelp segment generated $950.4 million in revenue in fiscal year 2025.
Parent Company
Acquired
2015
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| BetterHelp | Teladoc Health, Inc. | Wholly owned |
BetterHelp's corporate entity was incorporated in Delaware on October 24, 2012, as Compile, Inc. Founders Alon Matas and Danny Bragonier launched the service in 2013 after Matas experienced how difficult, expensive, and inaccessible traditional therapy could be. The product matched users with licensed therapists for counseling delivered through the web, phone, video, and unlimited messaging.
The model caught on quickly with younger consumers priced out of or geographically distant from in-person care. Teladoc, then the largest US telehealth company, bought the two-year-old startup in January 2015 for a headline price of about $4.5 million plus earnout.
Under Teladoc, BetterHelp scaled through aggressive direct-response marketing, becoming a dominant sponsor of podcasts, YouTube channels, and influencer content. By the late 2010s it was the largest online counseling platform in the world, and it expanded with affiliated services including Teen Counseling, Pride Counseling, and Regain for couples.
The pandemic accelerated demand sharply, and BetterHelp became Teladoc's growth engine while the core telehealth business matured. In March 2023 the Federal Trade Commission announced a settlement with BetterHelp over disclosure of user health data to advertisers, resulting in a $7.8 million refund program and a ban on sharing health data for advertising.
A strategic shift came in 2025: after years as a cash-pay-only service, BetterHelp began accepting insurance coverage in the United States, expanding to 20 states plus Washington, D.C., and reaching more than 120 million covered lives through in-network agreements. The move responded to softening direct-pay demand; segment revenue fell 9% to $950.4 million in FY2025, while paying users averaged about 390,000 per month.
Is Teladoc Health publicly traded?
Yes. Teladoc trades on the New York Stock Exchange under ticker TDOC. It listed in July 2015, the first major US telehealth IPO.
Who founded Teladoc?
G. Byron Brooks and Michael Gorton founded the company in Texas in 2002, initially offering physician consultations by phone.
What does Teladoc own?
Its principal brands are the Integrated Care enterprise business, the BetterHelp therapy platform (with affiliated services Teen Counseling, Pride Counseling, and Regain), Best Doctors, and Catapult Health.
Where is Teladoc headquartered?
Teladoc Health is headquartered in Purchase, New York, United States. BetterHelp operates from Mountain View, California.
Did Teladoc buy BetterHelp?
Yes. Teladoc acquired BetterHelp in January 2015 for $3.5 million in cash, a $1 million promissory note, and three years of revenue-based seller payments, one of the most profitable small acquisitions in digital health history.
Does Teladoc make a profit?
Not on a GAAP basis. FY2025 net loss was $200.3 million, narrowed from $1.0 billion in FY2024. Adjusted EBITDA was $281.1 million.
BetterHelp's ethics profile centres on patient privacy, which is also the subject of its most significant regulatory action. Beyond that, the platform's scale gives it a measurable social footprint: therapy access for users in rural areas and countries with limited mental health infrastructure.
The company states that it does not sell user data and that clinical conversations are private. Its advertising practices underwent a formal reset following the 2023 FTC order described below.
FTC data-sharing settlement (2023): In March 2023 the Federal Trade Commission announced that BetterHelp had shared sensitive user data, including email addresses, IP addresses, and health questionnaire responses, with Facebook, Snapchat, Pinterest, and Criteo for advertising purposes, despite privacy promises to users. BetterHelp agreed to pay $7.8 million to refund affected consumers and was banned from sharing health data for advertising. The company did not admit wrongdoing but accepted the consent order.
Advertising scrutiny (2018 to 2020): The platform faced criticism over influencer sponsorships where creators disclosed mental health struggles while promoting the service, and over terms of service that appeared to disclaim responsibility for verifying therapist credentials. BetterHelp updated its disclosures and tightened credential language; it states that all network clinicians are licensed.
Therapist quality debates (ongoing): Press coverage has documented individual user complaints about mismatched or unresponsive therapists. BetterHelp operates a rematching system, and no regulator has found systemic credentialing failures.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Zocdoc | USA | 2007 | Mass market | United states | All Genders |
Market Positioning: BetterHelp competes with 1 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Teladoc Health, Inc., giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Zocdoc, Inc.
Online healthcare marketplace where patients find in-network doctors and book appointments instantly, a private New York company valued at $1.8 billion.
Zocdoc is privately owned, unlike BetterHelp which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by All Family Pharmacy LLC
Boca Raton mail-order pharmacy at allfamilypharmacy.com known for direct-to-consumer access to ivermectin, hydroxychloroquine, and 200-plus medications.
All Family Pharmacy is privately owned, unlike BetterHelp which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Chempro Chemists
Australian online pharmacy operated by Chempro Chemists from Molendinar, Queensland. Offers prescription medications, health products, and wellness items through digital platforms and mail-order delivery.
Pharmacy Direct is privately owned, unlike BetterHelp which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by TTAM Research Institute
Consumer DNA testing brand now run as a nonprofit under TTAM Research Institute following the 2025 bankruptcy sale of 23andMe Holding Co.
23andMe is privately owned, unlike BetterHelp which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Adcock Ingram Holdings Limited
South African pharmaceutical brand behind Panado and Myprodol, now privately held by Bidvest and NATCO Pharma.
Adcock Ingram is privately owned, unlike BetterHelp which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Alfa-Pharm CJSC
Armenia's largest pharmaceutical distributor and pharmacy chain, importing medicines from more than 70 global manufacturers since 1996.
Alfa-Pharm is privately owned, unlike BetterHelp which is under a publicly traded parent company.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Consumer DNA testing brand now run as a nonprofit under TTAM Research Institute following the 2025 bankruptcy sale of 23andMe Holding Co.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Abbott Laboratories' medical device business spanning cardiovascular, diabetes care (FreeStyle Libre), neuromodulation, and structural heart, generating roughly $20 billion annually.